Urology News and Research

Latest Urology News and Research

Actavis creates collaborative program to improve care for patients with multidrug-resistant infections

Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.

27 May 2015

Study shows superiority of Cxbladder Detect over other non-invasive bladder cancer diagnostic tool

Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used tests was published online this week in the peer-reviewed Open Access medical journal BioMed Central ("BMC") Medical Research Methodology.

27 May 2015

GHIT Fund expands investments in leishmaniasis, diagnostic tests

The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million.

22 May 2015

RCC benefit independent of sorafenib, sunitinib sequence order

Sequential treatment with sorafenib followed by sunitinib is not superior to sunitinib followed by sorafenib in patients with advanced or metastatic renal cell carcinoma, suggests research published in European Urology.

21 May 2015

First-line axitinib ‘feasible’ in advanced, metastatic RCC

A Japanese single-institution study suggests that axitinib may be a feasible first-line option for patients with locally advanced or metastatic renal cell carcinoma.

21 May 2015

Endomag named finalist for Royal Academy of Engineering's MacRobert Award

Cancer healthcare company Endomag has been revealed as a finalist for the UK’s most prestigious engineering award. Endomag, which was shortlisted for its innovative breast cancer staging diagnostic system Sentimag and Sienna+, is one of three companies up for the MacRobert Award from the Royal Academy of Engineering.

21 May 2015

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, supports efforts to bring the medical community the first ever treatment guidelines for Peyronie's Disease (PD), a condition in which collagen plaque, or scar tissue, develops on the shaft of the penis, and may harden and reduce flexibility.

19 May 2015

Mi-Prostate Score improves prostate cancer detection

A new urine-based test improved prostate cancer detection - including detecting more aggressive forms of prostate cancer - compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.

19 May 2015

Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

As many as 12 percent of patients undergoing major, non-cardiac surgery experience an irregular heartbeat called atrial fibrillation.

19 May 2015

New studies to improve prostate cancer detection to be presented at AUA annual meeting

Five new studies evaluating the use of imaging and urine-based biomarkers as ways to improve prostate cancer detection will be presented during the 110th Annual Scientific Meeting of the American Urological Association (AUA).

18 May 2015

Lumenis and top urologists to host instructive workshop series at AUA 2015

Lumenis Ltd., the world's largest energy-based medical device company for surgical, ophthalmology, and aesthetic applications announced today that the company will host an educational symposium, in collaboration with nationally distinguished urologists, and an instructive workshop series at the American Urological Association's (AUA) 2015 Annual Meeting, being held in New Orleans, La., from May 15 – 19, 2015.

From Lumenis Inc. 18 May 2015

Current fee-for-service models in U.S. healthcare may jeopardize prostate surgery patients

A "perverse disincentive" for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led by Henry Ford Hospital researchers.

18 May 2015

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use.

17 May 2015

Botulinum toxin A effective for treating bladder disorders

While Botulinum toxin A (BTX-A), known to the public as Botox, is commonly associated with smoothing wrinkles for a more youthful appearance, three studies presented at the 110th Annual Scientific Meeting of the American Urological Association are proving BTX-A to be more than just a cosmetic solution.

17 May 2015

Active surveillance appears to be safer management strategy for prostate cancer patients

Four studies evaluating effectiveness, trends and other considerations for active surveillance in managing prostate cancer will be presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Delaying kidney stone treatment could lead to increased costs, patient morbidity

Delaying treatment of kidney stones could lead to increased costs and patient morbidity, according to a new study presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Study highlights link between poor sleep quality and impact of severe LUTS in some men

Sleep quality may have an impact on the severity of lower urinary tract symptoms, or LUTS, in some men, according to new research presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Quitting smoking can help improve outcomes after major urologic surgery

Quitting smoking can lead to a significant improvement in outcomes after major urologic surgery. These new data and their impact on urologic surgery will be highlighted by study authors during a special press conference at the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Exposure to secondhand cannabis smoke causes mild intoxication

Researchers recruited seven people ages 18 to 45 who said they smoked cannabis at least twice per week and tested positive for THC, but who tested negative for other drugs, and 12 others in the same age range who said they had not used cannabis in the past six months and tested negative for cannabis, other drugs, and alcohol...

14 May 2015

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under "extreme conditions," such as an unventilated room or enclosed vehicle, can cause nonsmokers to feel the effects of the drug, have minor problems with memory and coordination, and in some cases test positive for the drug in a urinalysis.

14 May 2015

Urology News and Research

Latest Urology News and Research

Actavis creates collaborative program to improve care for patients with multidrug-resistant infections

Study shows superiority of Cxbladder Detect over other non-invasive bladder cancer diagnostic tool

GHIT Fund expands investments in leishmaniasis, diagnostic tests

RCC benefit independent of sorafenib, sunitinib sequence order

First-line axitinib ‘feasible’ in advanced, metastatic RCC

Endomag named finalist for Royal Academy of Engineering's MacRobert Award

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Mi-Prostate Score improves prostate cancer detection

Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

New studies to improve prostate cancer detection to be presented at AUA annual meeting

Lumenis and top urologists to host instructive workshop series at AUA 2015

Current fee-for-service models in U.S. healthcare may jeopardize prostate surgery patients

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Botulinum toxin A effective for treating bladder disorders

Active surveillance appears to be safer management strategy for prostate cancer patients

Delaying kidney stone treatment could lead to increased costs, patient morbidity

Study highlights link between poor sleep quality and impact of severe LUTS in some men

Quitting smoking can help improve outcomes after major urologic surgery

Exposure to secondhand cannabis smoke causes mild intoxication

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in